Advertisement
Home »

The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy.

Jul 10, 2023

ABOUT THE EXPERTS

  • Kuebra Oezer

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Kuebra.Acunman@gmail.com.

    Matthias Kolibabka

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

    Johann Gassenhuber

    Sanofi, MSAT M&I Bioassays and Compliance, Frankfurt, Germany.

    Nadine Dietrich

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

    Thomas Fleming

    Department of Medicine I and Clinical Chemistry, Heidelberg University, Heidelberg, Germany.

    German Center for Diabetes Research (DZD), Neuherberg, Germany.

    Andrea Schlotterer

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

    Michael Morcos

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

    Stoffwechselzentrum Rhein-Pfalz, Belchenstraße 1-5, 68163, Mannheim, Germany.

    Paulus Wohlfart

    Sanofi, MSAT M&I Bioassays and Compliance, Frankfurt, Germany.

    Hans-Peter Hammes

    5th Medical Department, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement